These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Possible paliperidone-related pons infarction. Chang CC; Wang WF; Lai TJ J Neuropsychiatry Clin Neurosci; 2014; 26(1):E15-6. PubMed ID: 24515693 [No Abstract] [Full Text] [Related]
26. Tardive dyskinesia induced by a switch from haloperidol depot to paliperidone palmitate. Hsu CY; Lin YH; Shen YC J Neuropsychiatry Clin Neurosci; 2013; 25(4):E46-7. PubMed ID: 24247889 [No Abstract] [Full Text] [Related]
27. Extrapyramidal side effects and tolerability of risperidone: a review. Owens DG J Clin Psychiatry; 1994 May; 55 Suppl():29-35. PubMed ID: 7520906 [TBL] [Abstract][Full Text] [Related]
28. Acute pisa syndrome and pharnygolaryngeal dystonia due to ziprasidone. Duggal HS J Neuropsychiatry Clin Neurosci; 2008; 20(1):108-9. PubMed ID: 18305296 [No Abstract] [Full Text] [Related]
29. A double-blind, placebo-controlled, randomized study evaluating the effect of paliperidone extended-release tablets on sleep architecture in patients with schizophrenia. Luthringer R; Staner L; Noel N; Muzet M; Gassmann-Mayer C; Talluri K; Cleton A; Eerdekens M; Battisti WP; Palumbo JM Int Clin Psychopharmacol; 2007 Sep; 22(5):299-308. PubMed ID: 17690599 [TBL] [Abstract][Full Text] [Related]
30. Molecule of the month. Paliperidone. Drug News Perspect; 2007 Jun; 20(5):333. PubMed ID: 17878961 [No Abstract] [Full Text] [Related]
31. What are the nursing implications when using paliperidone prolonged release for people with schizophrenia. Jones A J Psychiatr Ment Health Nurs; 2008 Dec; 15(10):792-9. PubMed ID: 19012670 [TBL] [Abstract][Full Text] [Related]
32. Paliperidone-induced mania-like symptoms: a case report. Wang WT; Chen CH; Lu ML; Lai TJ Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1351-2. PubMed ID: 20600461 [No Abstract] [Full Text] [Related]
33. Paliperidone (Invega) for schizophrenia. Med Lett Drugs Ther; 2007 Mar; 49(1256):21-3. PubMed ID: 17351558 [No Abstract] [Full Text] [Related]
34. Tardive dystonic symptoms associated with aripiprazole treatment. Lim HK; Pae CU; Lee C; Lee CU Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):589-90. PubMed ID: 18053627 [No Abstract] [Full Text] [Related]
35. Parkinsonism and rabbit syndrome after discontinuation of low-dose ziprasidone and concomitant initiation of sertraline. Gray JA J Clin Psychopharmacol; 2012 Feb; 32(1):142-3. PubMed ID: 22217953 [No Abstract] [Full Text] [Related]
36. Relationship between inflammation and metabolic syndrome following treatment with paliperidone for schizophrenia. Na KS; Kim WH; Jung HY; Ryu SG; Min KJ; Park KC; Kim YS; Yoon JS; Ahn YM; Kim CE Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):295-300. PubMed ID: 22796278 [TBL] [Abstract][Full Text] [Related]
37. Pisa syndrome in a Chinese patient. Chiu HF; Li SW; Lee S Aust N Z J Psychiatry; 1989 Mar; 23(1):127-8. PubMed ID: 2564768 [TBL] [Abstract][Full Text] [Related]
38. Management of a risperidone-induced tardive Pisa syndrome: a case report. Kaufmann A; Boesch S; Fleischhacker WW; Hofer A J Clin Psychopharmacol; 2012 Jun; 32(3):418-20. PubMed ID: 22561474 [No Abstract] [Full Text] [Related]
39. A comparison of serum prolactin concentrations after administration of paliperidone extended-release and risperidone tablets in patients with schizophrenia. Berwaerts J; Cleton A; Rossenu S; Talluri K; Remmerie B; Janssens L; Boom S; Kramer M; Eerdekens M J Psychopharmacol; 2010 Jul; 24(7):1011-8. PubMed ID: 19825908 [TBL] [Abstract][Full Text] [Related]
40. Higher frequency of neuroleptic-induced dystonia in mania than in schizophrenia. Nasrallah HA; Churchill CM; Hamdan-Allan GA Am J Psychiatry; 1988 Nov; 145(11):1455-6. PubMed ID: 2903686 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]